
Gufipra 40mg Injection
Marketer
Gufic Bioscience Ltd
Salt Composition
Enoxaparin (40mg)
Overview Gufipra 40mg Injection
Heparin 40mg Injection is an antithrombotic medication preventing and treating dangerous blood clots. It inhibits existing clot growth and formation of new clots. It's also used to prevent venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism. Administration is subcutaneous, performed by a healthcare professional; intramuscular injection is contraindicated. Dosage and treatment duration depend on individual factors including medical history, response to therapy, and underlying condition, potentially considering age and weight. Continued use is crucial, even without noticeable symptoms, to mitigate future complications; cessation increases thrombotic risk. Activities increasing bleeding or injury risk should be avoided. Common adverse effects comprise injection site discomfort, hemorrhage, cephalalgia, thrombocytosis, respiratory distress, edema, anemia, pyrexia, diarrhea, and elevated liver function tests. Severe headache may indicate intracranial bleeding; intense abdominal pain suggests gastrointestinal bleeding. Hemorrhage, potentially subtle, can be life-threatening; monitor for symptoms and report concerns promptly. Prior to use, disclose hypertension, diabetes, or recent cerebrovascular accident history to your physician. Contraindicated in active bleeding. Inform your doctor of all concurrent medications to ensure compatibility. Individuals with low body mass may experience heightened bleeding risk, exacerbated by alcohol consumption, increasing the probability of gastrointestinal hemorrhage.
Primary Ingredients of Gufipra 40mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Gufipra 40mg Injection
Managing and mitigating the risk of thrombosis
Major Benefits of Gufipra 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gufipra 40mg Injection:
- Bleeding
- Headache
- Low blood platelets
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Fever
- Injection site pain
- Breathing problems
- Edema (swelling)
- Diarrhea
How to use Gufipra 40mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is not advised.
How Gufipra 40mg Injection works:
Gufipra 40mg Injection is a medication that thins the blood. Its mechanism involves neutralizing specific clotting factors, thereby inhibiting clot development and reducing the risk of vascular obstructions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Gufipra 40mg Injection may pose unknown risks. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable medication Gufipra, 40mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Gufipra 40mg Injection while breastfeeding is likely safe. Studies in humans show minimal risk to the infant. The drug's transfer to breast milk is low, resulting in negligible quantities reaching the baby, posing no apparent threat.
DrivingSAFE
Driving ability is typically unaffected by Gufipra 40mg Injection.
KidneyCAUTION
Gufipra 40mg Injection requires careful administration for individuals with impaired kidney function. Dosage modification of Gufipra 40mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gufipra 40mg Injection to individuals with hepatic impairment. Physician consultation is recommended. Nevertheless, prudent application is suggested for patients exhibiting pre-existing liver conditions.
What if you forget to take Gufipra 40mg Injection :
Omit a Gufipra 40mg Injection dose? Seek medical advice immediately.
Facts to Know About Gufipra 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Low-molecular-weight heparin |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Low-molecular-weight heparin (LMWH) |
